TY - JOUR
T1 - Cardiac Rehabilitation in Severe Heart Failure Patients with Impella 5.0 Support via the Subclavian Artery Approach Prior to Left Ventricular Assist Device Implantation
AU - Shimizu, Miho
AU - Hiraiwa, Hiroaki
AU - Tanaka, Shinya
AU - Tsuchikawa, Yohei
AU - Ito, Ryota
AU - Kazama, Shingo
AU - Kimura, Yuki
AU - Araki, Takashi
AU - Mizutani, Takashi
AU - Oishi, Hideo
AU - Kuwayama, Tasuku
AU - Kondo, Toru
AU - Morimoto, Ryota
AU - Okumura, Takahiro
AU - Ito, Hideki
AU - Yoshizumi, Tomo
AU - Mutsuga, Masato
AU - Usui, Akihiko
AU - Murohara, Toyoaki
N1 - Publisher Copyright:
© 2023 by the authors.
PY - 2023/4
Y1 - 2023/4
N2 - Impella 5.0 circulatory support via subclavian artery (SA) access may be a safe approach for patients undergoing cardiac rehabilitation (CR). In this case series, we retrospectively analyzed the demographic characteristics, physical function, and CR data of six patients who underwent Impella 5.0 implantation via the SA prior to left ventricular assist device (LVAD) implantation between October 2013 and June 2021. The median age was 48 years, and one patient was female. Grip strength was maintained or increased in all patients before LVAD implantation (pre-LVAD) compared to after Impella 5.0 implantation. The pre-LVAD knee extension isometric strength (KEIS) was less than 0.46 kgf/kg in two patients and more than 0.46 kgf/kg in three patients (unavailable KEIS data, n = 1). With Impella 5.0 implantation, two patients could ambulate, one could stand, two could sit on the edge of the bed, and one remained in bed. One patient lost consciousness during CR due to decreased Impella flow. There were no other serious adverse events. Impella 5.0 implantation via the SA allows mobilization, including ambulation, prior to LVAD implantation, and CR can be performed relatively safely.
AB - Impella 5.0 circulatory support via subclavian artery (SA) access may be a safe approach for patients undergoing cardiac rehabilitation (CR). In this case series, we retrospectively analyzed the demographic characteristics, physical function, and CR data of six patients who underwent Impella 5.0 implantation via the SA prior to left ventricular assist device (LVAD) implantation between October 2013 and June 2021. The median age was 48 years, and one patient was female. Grip strength was maintained or increased in all patients before LVAD implantation (pre-LVAD) compared to after Impella 5.0 implantation. The pre-LVAD knee extension isometric strength (KEIS) was less than 0.46 kgf/kg in two patients and more than 0.46 kgf/kg in three patients (unavailable KEIS data, n = 1). With Impella 5.0 implantation, two patients could ambulate, one could stand, two could sit on the edge of the bed, and one remained in bed. One patient lost consciousness during CR due to decreased Impella flow. There were no other serious adverse events. Impella 5.0 implantation via the SA allows mobilization, including ambulation, prior to LVAD implantation, and CR can be performed relatively safely.
UR - http://www.scopus.com/inward/record.url?scp=85154607418&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85154607418&partnerID=8YFLogxK
U2 - 10.3390/jpm13040630
DO - 10.3390/jpm13040630
M3 - Article
AN - SCOPUS:85154607418
SN - 2075-4426
VL - 13
JO - Journal of Personalized Medicine
JF - Journal of Personalized Medicine
IS - 4
M1 - 630
ER -